Latent Hypoparathyroidism in an Osteoporotic Patient with Multiple Endocrinopathies and Secondary Hemochromatosis due to Multiple Blood Transfusions, Unmasked by Alendronate and Glucocorticoid at Adrenal Crisis-Reference-Cited by-同舟云学术

Latent Hypoparathyroidism in an Osteoporotic Patient with Multiple Endocrinopathies and Secondary Hemochromatosis due to Multiple Blood Transfusions, Unmasked by Alendronate and Glucocorticoid at Adrenal Crisis

Published:2008 Issue:6 Volume:47 Page:515-520
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Tanimoto Keiji¹,Okubo Yumiko¹,Harada Chie¹,Saito Hiroshi¹,Sata Akira¹,Nishikawa Aiko¹,Ohwada Rina¹,Tsuiki Mika¹,Yamamoto Masaaki¹,Hashimoto Etsuko²,Sato Kanji¹,Takano Kazue¹

Affiliation:

1. Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women's Medical University

2. Department of Medicine, Institute of Gastroenterology, Tokyo Women's Medical University

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

http://www.jstage.jst.go.jp/article/internalmedicine/47/6/47_6_515/_pdf

Reference29 articles.

1. 1. Goltzman D, Cole DEC. Hypoparathyriodism. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Fifth edition. Favus MJ, Ed. American Society for Bone and Mineral Research, Washington, D.C., 2003: 274-278.

2. Nocturnal calcium, phosphorus and parathyroid hormone in the diagnosis of concealed and subclinical hypoparathyroidism

3. Hemochromatosis and Hemosiderosis

4. Hypoparathyroidism and iron storage disease. Treatment with 25-hydroxy-vitamin D3

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Presentation of Hypoparathyroidism;Parathyroid Disorders;2018-11-19

2. Clinical Manifestations of Hypoparathyroidism;The Parathyroids;2015

3. Rare Causes of Acquired Hypoparathyroidism;Hypoparathyroidism;2015

4. Hypoparathyroidism and Subclinical Hypothyroidism with Secondary Hemochromatosis;Endocrinology and Metabolism;2014

5. Risk factors for development of atypical femoral fractures in patients on long-term oral bisphosphonate therapy;Bone;2013-10